Clinical Trials
6 trialsNCT07389876 2026-02-05
G/GEJ
Fudan University
Recruiting
NCT06777628 2025-01-16
Immunecheck
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Recruiting
NCT06423144 2024-05-21
PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7
Shanghai Zhongshan Hospital
Unknown
NCT04639284 2021-07-26
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
Shanghai Zhongshan Hospital
Unknown
NCT04912128 2021-06-03
AnloSBRT
Peking University Third Hospital
Completed
NCT04137588 2021-02-24
Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Unknown